Micro Labs Limited Discontinued
FDA Approved Drugs

Micro Labs Limited Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 9
  • Latest Approval Date Aug 04, 2023
  • Data Source FDA
  • First Approval Date Feb 26, 1999
All
214
View
Unclassified
14
View
Discontinued
9
View
RX
191
View
Company Overview

Company

Micro Labs Limited Discontinued

Country

India

Website

Visit Website

Email

Social Profiles

LinkedIn
Company Snapshot

Micro Labs Limited Discontinued

27, RACE COURSE ROAD, BANGALORE-560 001

India

www.microlabsltd.com/ View on Map
FDA Approved Drug Records ( 9 records )
2019
23 Dec
Discontinued Application: 210013

Drug Name

APIXABAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2019-12-23

210013 / 1

Active Ingredient

APIXABAN

Application Number

210013

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2019-12-23

Regulatory Status

Discontinued

2019
23 Dec
Discontinued Application: 210013

Drug Name

APIXABAN

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2019-12-23

210013 / 2

Active Ingredient

APIXABAN

Application Number

210013

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2019-12-23

Regulatory Status

Discontinued

2022
02 Feb
Discontinued Application: 211925

Drug Name

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE;5MG

Approval Date

2022-02-02

211925 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Application Number

211925

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE;5MG

Approval Date

2022-02-02

Regulatory Status

Discontinued

2022
02 Feb
Discontinued Application: 211925

Drug Name

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE;10MG

Approval Date

2022-02-02

211925 / 2

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Application Number

211925

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE;10MG

Approval Date

2022-02-02

Regulatory Status

Discontinued

1999
26 Feb
Discontinued Application: 74986

Drug Name

DICLOFENAC SODIUM

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1999-02-26

74986 / 1

Active Ingredient

DICLOFENAC SODIUM

Application Number

74986

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1999-02-26

Regulatory Status

Discontinued

1999
26 Feb
Discontinued Application: 74986

Drug Name

DICLOFENAC SODIUM

Product Number

2

Dosage Form

-

Strength

75MG

Approval Date

1999-02-26

74986 / 2

Active Ingredient

DICLOFENAC SODIUM

Application Number

74986

Product Number

2

Dosage Form

-

Strength

75MG

Approval Date

1999-02-26

Regulatory Status

Discontinued

2018
13 Aug
Discontinued Application: 205626

Drug Name

LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

150MG;200MG;300MG

Approval Date

2018-08-13

205626 / 1

Active Ingredient

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Application Number

205626

Product Number

1

Dosage Form

-

Strength

150MG;200MG;300MG

Approval Date

2018-08-13

Regulatory Status

Discontinued

2023
04 Aug
Discontinued Application: 215081

Drug Name

LIFITEGRAST

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2023-08-04

215081 / 1

Active Ingredient

LIFITEGRAST

Application Number

215081

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2023-08-04

Regulatory Status

Discontinued

2012
14 Dec
Discontinued Application: 201952

Drug Name

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

325MG;37.5MG

Approval Date

2012-12-14

201952 / 1

Active Ingredient

ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

Application Number

201952

Product Number

1

Dosage Form

-

Strength

325MG;37.5MG

Approval Date

2012-12-14

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    21 View
  • EDQM CEP
    50 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    25 View
  • FDA Approved Drugs Database
    214 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
9 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

APIXABAN

Application Number

210013

Product Number

1

Active Ingredient

APIXABAN

Dosage Form

-

Strength

2.5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit